1. Home
  2. VITL vs CDNA Comparison

VITL vs CDNA Comparison

Compare VITL & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vital Farms Inc.

VITL

Vital Farms Inc.

HOLD

Current Price

$20.02

Market Cap

944.3M

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$18.84

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VITL
CDNA
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.3M
1.0B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
VITL
CDNA
Price
$20.02
$18.84
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$42.56
$27.33
AVG Volume (30 Days)
2.1M
655.1K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
22.03
N/A
EPS
1.44
N/A
Revenue
$759,444,000.00
$48,324,000.00
Revenue This Year
$26.07
$15.37
Revenue Next Year
$20.95
$11.23
P/E Ratio
$13.90
N/A
Revenue Growth
25.26
18.93
52 Week Low
$19.75
$10.96
52 Week High
$53.13
$21.49

Technical Indicators

Market Signals
Indicator
VITL
CDNA
Relative Strength Index (RSI) 23.17 45.09
Support Level N/A $18.30
Resistance Level $31.02 $20.94
Average True Range (ATR) 1.24 0.86
MACD -0.58 -0.05
Stochastic Oscillator 3.04 52.31

Price Performance

Historical Comparison
VITL
CDNA

About VITL Vital Farms Inc.

Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: